HUP0202630A2 - Meiózisra ható anyagokat tartalmazó készítmények - Google Patents
Meiózisra ható anyagokat tartalmazó készítményekInfo
- Publication number
- HUP0202630A2 HUP0202630A2 HU0202630A HUP0202630A HUP0202630A2 HU P0202630 A2 HUP0202630 A2 HU P0202630A2 HU 0202630 A HU0202630 A HU 0202630A HU P0202630 A HUP0202630 A HU P0202630A HU P0202630 A2 HUP0202630 A2 HU P0202630A2
- Authority
- HU
- Hungary
- Prior art keywords
- compositions containing
- activating substance
- meiosis activating
- meiosis
- substance
- Prior art date
Links
- 230000021121 meiosis Effects 0.000 title abstract 2
- 230000003213 activating effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000004720 fertilization Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000012265 solid product Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
A jelen találmány az in vitro megtermékenyítéssel kapcsolatbanhasználható szilárd termékekre vonatkozik, melyek meiózisra hatóanyagokat tartalmaznak. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199901308 | 1999-09-16 | ||
PCT/DK2000/000500 WO2001019354A2 (en) | 1999-09-16 | 2000-09-11 | Composition for ivf |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0202630A2 true HUP0202630A2 (hu) | 2002-12-28 |
HUP0202630A3 HUP0202630A3 (en) | 2004-06-28 |
Family
ID=8103409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202630A HUP0202630A3 (en) | 1999-09-16 | 2000-09-11 | Compositions containing meiosis activating substance |
Country Status (21)
Country | Link |
---|---|
US (1) | US6844313B1 (hu) |
EP (1) | EP1216059B1 (hu) |
JP (1) | JP2003509365A (hu) |
KR (1) | KR100757909B1 (hu) |
CN (1) | CN1222319C (hu) |
AT (1) | ATE306942T1 (hu) |
AU (1) | AU781994B2 (hu) |
BR (1) | BR0014058A (hu) |
CA (1) | CA2382908A1 (hu) |
CZ (1) | CZ2002591A3 (hu) |
DE (1) | DE60023324T2 (hu) |
ES (1) | ES2252048T3 (hu) |
HU (1) | HUP0202630A3 (hu) |
IL (1) | IL148234A0 (hu) |
MX (1) | MXPA02002439A (hu) |
NO (1) | NO323694B1 (hu) |
PL (1) | PL202224B1 (hu) |
RU (1) | RU2263516C2 (hu) |
UA (1) | UA78183C2 (hu) |
WO (1) | WO2001019354A2 (hu) |
ZA (1) | ZA200201383B (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ20012671A3 (cs) * | 1999-02-26 | 2002-01-16 | Novo Nordisk A/S | Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu |
ATE306942T1 (de) | 1999-09-16 | 2005-11-15 | Novo Nordisk As | Zusammensetzung zur in-vitro befruchtung |
WO2001062258A2 (en) * | 2000-02-25 | 2001-08-30 | Schering Aktiengesellschaft | Improvement of implantation rate using ff-mas |
US6988613B2 (en) | 2001-02-06 | 2006-01-24 | Novo Nordisk A/S | Composition for IVF |
EP1245572A1 (en) | 2001-03-26 | 2002-10-02 | Schering Aktiengesellschaft | Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4175074A (en) | 1976-08-23 | 1979-11-20 | Deshmukh Arvind D | Serum-soluble cholesterol compounds and method for their preparation |
US4751219A (en) | 1985-02-05 | 1988-06-14 | Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek | Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides |
AU4312489A (en) * | 1988-09-23 | 1990-04-18 | Cetus Corporation | Lipid microemulsions for culture media |
DE4221880A1 (de) | 1992-07-03 | 1994-01-05 | Alfatec Pharma Gmbh | Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen |
EP0674506B1 (en) * | 1992-12-02 | 2000-08-23 | Alkermes Controlled Therapeutics, Inc. | Controlled release growth hormone containing microspheres |
US5716777A (en) * | 1994-06-23 | 1998-02-10 | Novo Nordisk A/S | Regulation of meiosis using sterols |
US6281015B1 (en) * | 1994-12-16 | 2001-08-28 | Children's Medical Center Corp. | Localized delivery of factors enhancing survival of transplanted cells |
EP0813595A1 (en) | 1995-03-06 | 1997-12-29 | Novo Nordisk A/S | Stimulation of meiosis |
CN1191543A (zh) | 1995-06-23 | 1998-08-26 | 诺沃挪第克公司 | 减数分裂调控化合物 |
GB9625175D0 (en) * | 1996-12-04 | 1997-01-22 | Medi Cult As | Serum-free cell culture media |
IL130249A0 (en) * | 1996-12-20 | 2000-06-01 | Novo Nordisk As | Meiosis regulating compounds |
KR20010013401A (ko) | 1997-06-04 | 2001-02-26 | 에프.지.엠. 헤르만스 | 감수분열 조절용 17β-알릴옥시(티오)알킬-안드로스탄유도체 |
HUP9701554D0 (en) | 1997-09-18 | 1997-11-28 | Human Oltoanyagtermeloe Gyogys | Pharmaceutical composition containing plazma proteins |
CA2333320A1 (en) | 1998-05-26 | 1999-12-02 | Schering Aktiengesellschaft | Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
CZ20012671A3 (cs) * | 1999-02-26 | 2002-01-16 | Novo Nordisk A/S | Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu |
ATE306942T1 (de) | 1999-09-16 | 2005-11-15 | Novo Nordisk As | Zusammensetzung zur in-vitro befruchtung |
-
2000
- 2000-09-11 AT AT00958274T patent/ATE306942T1/de not_active IP Right Cessation
- 2000-09-11 MX MXPA02002439A patent/MXPA02002439A/es active IP Right Grant
- 2000-09-11 ES ES00958274T patent/ES2252048T3/es not_active Expired - Lifetime
- 2000-09-11 DE DE60023324T patent/DE60023324T2/de not_active Expired - Fee Related
- 2000-09-11 CZ CZ2002591A patent/CZ2002591A3/cs unknown
- 2000-09-11 CA CA002382908A patent/CA2382908A1/en not_active Abandoned
- 2000-09-11 IL IL14823400A patent/IL148234A0/xx unknown
- 2000-09-11 BR BR0014058-9A patent/BR0014058A/pt not_active Application Discontinuation
- 2000-09-11 EP EP00958274A patent/EP1216059B1/en not_active Expired - Lifetime
- 2000-09-11 JP JP2001522989A patent/JP2003509365A/ja active Pending
- 2000-09-11 HU HU0202630A patent/HUP0202630A3/hu unknown
- 2000-09-11 WO PCT/DK2000/000500 patent/WO2001019354A2/en active IP Right Grant
- 2000-09-11 RU RU2002109794/15A patent/RU2263516C2/ru not_active IP Right Cessation
- 2000-09-11 PL PL353968A patent/PL202224B1/pl not_active IP Right Cessation
- 2000-09-11 AU AU69850/00A patent/AU781994B2/en not_active Ceased
- 2000-09-11 KR KR1020027003526A patent/KR100757909B1/ko not_active IP Right Cessation
- 2000-09-11 CN CNB008128820A patent/CN1222319C/zh not_active Expired - Fee Related
- 2000-09-14 US US09/661,696 patent/US6844313B1/en not_active Expired - Fee Related
- 2000-11-09 UA UA2002032077A patent/UA78183C2/uk unknown
-
2002
- 2002-02-19 ZA ZA200201383A patent/ZA200201383B/en unknown
- 2002-03-15 NO NO20021309A patent/NO323694B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2382908A1 (en) | 2001-03-22 |
DE60023324D1 (de) | 2005-11-24 |
DE60023324T2 (de) | 2006-07-20 |
ZA200201383B (en) | 2002-11-27 |
JP2003509365A (ja) | 2003-03-11 |
UA78183C2 (en) | 2007-03-15 |
RU2263516C2 (ru) | 2005-11-10 |
EP1216059A2 (en) | 2002-06-26 |
AU6985000A (en) | 2001-04-17 |
CN1222319C (zh) | 2005-10-12 |
AU781994B2 (en) | 2005-06-23 |
ATE306942T1 (de) | 2005-11-15 |
MXPA02002439A (es) | 2002-07-30 |
KR100757909B1 (ko) | 2007-09-11 |
WO2001019354A2 (en) | 2001-03-22 |
BR0014058A (pt) | 2004-03-30 |
IL148234A0 (en) | 2002-09-12 |
HUP0202630A3 (en) | 2004-06-28 |
NO323694B1 (no) | 2007-06-25 |
WO2001019354A3 (en) | 2001-06-14 |
NO20021309D0 (no) | 2002-03-15 |
ES2252048T3 (es) | 2006-05-16 |
NO20021309L (no) | 2002-03-15 |
PL353968A1 (en) | 2003-12-15 |
CN1373675A (zh) | 2002-10-09 |
KR20020032593A (ko) | 2002-05-03 |
US6844313B1 (en) | 2005-01-18 |
EP1216059B1 (en) | 2005-10-19 |
CZ2002591A3 (cs) | 2002-08-14 |
PL202224B1 (pl) | 2009-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE295347T1 (de) | Stoffe und zusammensetzungen für die verabreichung aktiver substanzen | |
PT1093819E (pt) | Compostos e composicoes para fornecimento de agentes activos | |
MY124214A (en) | Compositions for promoting crowth | |
ME00298B (me) | Farmaceutski preparat | |
BRPI0115953B8 (pt) | complexos de derivados de fosfato | |
SI1608346T1 (sl) | Spojine za sproščanje zdravilnih učinkovin na osnovi alfa-hidroksi kislinskih estrov in postopki njihove uporabe | |
HUP0200157A2 (hu) | A terméketlenség kezelése | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
ES2180319T3 (es) | Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos. | |
HUP0202630A2 (hu) | Meiózisra ható anyagokat tartalmazó készítmények | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
PL353209A1 (en) | Paracetamol and drotaverine containing composition | |
EP1011329A4 (en) | PACLITAXELS 7-METHYLTHIOOXOMETHYLE AND 7-METHYLTHIODIOXOMETHYLE | |
TR200103126T2 (tr) | Yapısal titremenin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri | |
GB9818445D0 (en) | Medicaments | |
ATE357246T1 (de) | Pharmazeutische träger zusammensetzung für produkte auf basis von papain | |
HN1999000007A (es) | Nuevas composiciones y metodos para uso en el cultivo de bananos y platanos. | |
AU8987198A (en) | Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative | |
TH49373A (th) | กรรมวิธีดูแลรักษาผมโดยจุดมุ่งหมายอยู่ที่เอ็นไซม์ | |
MD20040296A (ro) | Compoziţie farmaceutică, conţinând oxcarbazepină cu eliberare prelungită a ingredientului activ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |